Inverse Probability of Censoring Weighted Analysis to Adjust the Treatment Effect on Overall Survival for Subsequent Therapy: A Case Study in a Clinical Trial in Multiple Myeloma

Value Health. 2014 Nov;17(7):A546. doi: 10.1016/j.jval.2014.08.1770. Epub 2014 Oct 26.

Authors

P Thilakarathne¹, A Palumbo², J Diels¹, M Delforge³, S van Sanden⁴, M V Mateos⁵, O Chirita⁶, M A Dimopoulos⁷, H van de Velde⁸, J F San Miguel⁹

Affiliations

¹ Janssen Pharmaceutica N. V., Beerse, Belgium.
² University of Torino, Torino, Italy.
³ University Hospital Leuven, Leuven, Belgium.
⁴ EMEA HEMAR Analytics, Janssen EMEA, Beerse, Belgium.
⁵ Hospital Universitario de Salamanca, Salamanca, Spain.
⁶ Janssen, High Wycombe, UK.
⁷ Alexandra Hospital, Athens, Greece.
⁸ Johnson & Johnson ORD, Beerse, Belgium.
⁹ Hospital Universitario Salamanca, Salamanca, Spain.

PMID: 27201769
DOI: 10.1016/j.jval.2014.08.1770

No abstract available